BostonGene

About BostonGene

BostonGene is a precision oncology company offering an AI-powered multimodal molecular and immune profiling platform that analyzes tumor tissue, microenvironment, and host immunity. Its technology combines genomic and transcriptomic data with advanced analytics to guide biomarker discovery, patient stratification, and therapy decisions across oncology applications. Headquartered in Waltham, Massachusetts with international collaborations, BostonGene serves healthcare providers, pharma, and biotech to accelerate drug development and personalized cancer care.